StockData
Tenaya Therapeutics, Inc. logo

Tenaya Therapeutics, Inc. (TNYA) stock

TNYANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$0.31−0.02 (-4.93%)

Close on Nov 18, 2026Market cap $68.82MP/E –Yield –

Tenaya Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Tenaya Therapeutics's price to book ratio was 1.2× on Nov 11, 2026, against 2.2× a year earlier. Over the last 4 years it ranged from 0.3× to 2.9×, with a median of 1.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.2×+0.1
2025Dec 31, 20251.1×+0.1
2024Dec 31, 20241.0×−0.3
2023Dec 29, 20231.4×−0.0
2022Apr 29, 20221.4×+0.9
2021Dec 31, 20210.5×–

More Tenaya Therapeutics figures

See a number that looks wrong?